InfectionSource patient's disease statusStatus of exposed personRegimen
Invasive group A streptococcal infectionNecrotizing streptococcal fasciitis from presentation until 48 hours after initiation of antibioticHigh-risk household contacts*A single dose of penicillin G benzathine (600,000 units IM in patients weighing < 60 lb [27 kg] or 1,200,000 units IM in patients weighing = 60 lb)
plus
Rifampin (10 mg per kg twice daily orally, divided into two doses; maximum daily dosage: 600 mg) twice daily for four days
or
Clindamycin (20 mg per kg orally; maximum daily dosage: 900 mg) three times daily for 10 days
or
Azithromycin (Zithromax; 12 mg per kg orally; maximum daily dosage: 500 mg) daily for five days
Invasive meningococcal infectionFrom seven days before onset of illness until 24 hours after initiation of antibioticAny close contact regardless of vaccination statusCiprofloxacin (Cipro; a single dose of 500 mg orally)
or
Azithromycin (a single dose of 500 mg orally)
or
Ceftriaxone (Rocephin; a single dose of 250 mg IM)
or
Rifampin (600 mg orally, twice daily for two days)
Begin antimicrobial chemoprophylaxis as early as possible, but no more than 14 days after exposure
PertussisWithin 21 days of the onset of coughAll household and other close contacts regardless of vaccination statusAzithromycin (500 mg orally) on day 1, then 250 mg daily for four days
or
Clarithromycin (Biaxin; 500 mg orally) twice daily for10 days
or
Erythromycin (500 mg orally) four times daily for 14 days
or
Trimethoprim/sulfamethoxazole (160/800 mg orally) twice daily for seven to 14 days
TetanusAfter a tetanus-prone injury§Any person with an uncertain or incomplete history of completing a three-dose primary series of tetanus toxoid–containing vaccine, or if the most recent dose was given ≥ 10 years ago (for minor and clean wounds) or ≥ five years ago (for puncture wounds or wounds contaminated with dirt)Tetanus toxoid–containing vaccine (Td, Tdap, TT); add a single dose of tetanus immune globulin (250 units IM), except after minor and clean wounds, if it is unclear that the three-dose primary vaccination series has been completed||
TuberculosisUntreated active pulmonary or laryngeal tuberculosisEvery person at risk regardless of previous bacille Calmette-Guérin immunization or tuberculosis historyTuberculin skin test or interferon-gamma release assay should be performed at baseline and at eight to 12 weeks after exposure
If tuberculin skin test ≥ 5 mm or interferon assay is positive, for nine months treat with isoniazid plus vitamin B6